1. Home
  2. ACMR vs BEAM Comparison

ACMR vs BEAM Comparison

Compare ACMR & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACM Research Inc.

ACMR

ACM Research Inc.

HOLD

Current Price

$50.16

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$31.99

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACMR
BEAM
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
ACMR
BEAM
Price
$50.16
$31.99
Analyst Decision
Buy
Buy
Analyst Count
3
14
Target Price
$43.00
$46.00
AVG Volume (30 Days)
1.4M
2.0M
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
29.16
N/A
EPS
1.72
N/A
Revenue
$880,350,000.00
$55,701,000.00
Revenue This Year
$18.22
N/A
Revenue Next Year
$16.80
$26.52
P/E Ratio
$28.92
N/A
Revenue Growth
20.77
N/A
52 Week Low
$16.81
$13.53
52 Week High
$56.30
$36.44

Technical Indicators

Market Signals
Indicator
ACMR
BEAM
Relative Strength Index (RSI) 59.32 56.44
Support Level $50.80 $29.80
Resistance Level $56.30 $35.34
Average True Range (ATR) 2.79 2.80
MACD -0.12 0.14
Stochastic Oscillator 49.09 55.79

Price Performance

Historical Comparison
ACMR
BEAM

About ACMR ACM Research Inc.

ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: